---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-137105"
form_type: "8-K"
ticker: "OACC"
cik: "0002029769"
company_name: "Oaktree Acquisition Corp. III Life Sciences"
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:50:37.871264+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oaktree Acquisition Corp. III Life Sciences CFO resigns; Thomas Sweeney appointed CFO

## Summary
- Courtney Conigliaro resigned as CFO effective June 3, 2025; resignation not due to any disagreements.
- Board appointed Thomas Sweeney as CFO (principal accounting/financial officer) effective June 3, 2025.
- Sweeney is a Managing Director at Oaktree Capital Management; will not receive compensation from the company.
- Board confirmed Alvin Shih as chair of the audit committee.

## SEC filing metadata
- accession: 0001193125-25-137105
- form_type: 8-K
- ticker: OACC
- cik: 0002029769
- company_name: Oaktree Acquisition Corp. III Life Sciences
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/d61441d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-137105
- JSON: https://secwatch.observer/filing/0001193125-25-137105.json
- Plain text: https://secwatch.observer/filing/0001193125-25-137105.txt

## Key facts
- Executive change
  Courtney Conigliaro resigned as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm
- Executive change
  Thomas Sweeney was appointed as Chief Financial Officer at Oaktree Acquisition Corp. III Life Sciences.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2029769/000119312525137105/0001193125-25-137105-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.